FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

ValueSets, Realm US

14,182 resources

Source: Text:

By Version

By Authority

  • none: 1,981
  • hl7: 12,201

 

Start Prev Rows 2000 - 2200 Next

PackageVersionIdentityName/TitleStatusFMMWGDateAuthSource(s)
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1792.jsonUlcer [Genital, Perineal, or Perianal Area] (ICD10CM)active2023-06hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1797.jsonBronchial Wash (Specimen Type) (SNOMED)active2023-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1800.jsonNontuberculous Mycobacteria Infection, Pulmonary (Organism or Substance in Lab Results)active2023-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1803.jsonBacteria (Tests in Sputum Specimen by Culture and Identification Method)active2023-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1819.jsonLouseborne relapsing fever (Tests for Borrelia species)active2024-06hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1820.jsonLouseborne relapsing fever (Tests for Borrelia species in Blood)active2024-06hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1823.jsonBorrelia species (Organism or Substance in Lab Results)active2024-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1824.jsonSpirochetes (Organism or Substance in Lab Results)active2024-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1829.jsonPolyarthritis [Unspecified Cause] (SNOMED)active2024-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1835.jsonRheumatoid nodules (SNOMED)active2023-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1842.jsonVentilator associated event (Disorders) (SNOMED)active2024-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1844.jsonLeishmaniasis (Disorders) (SNOMED)active2023-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1846.jsonLeishmaniasis (Tests for Leishmania species Nucleic Acid)active2024-06hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1847.jsonLeishmaniasis (Tests for Leishmania species Antibody)active2023-06hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1848.jsonLeishmania species (Tests by Microscopic Observation in Tissue)active2024-06hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.185.jsonBrucellosis (Disorders) (SNOMED)active2024-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1864.jsonTaeniasis (Disorders) (SNOMED)active2023-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1866.jsonTaeniasis (Organism or Substance in Lab Results)active2024-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.187.jsonDengue Virus Infection (Disorders) (SNOMED)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1875.jsonCysticercosis (Tests for Taenia solium Antibody)active2023-06hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1878.jsonSurgical Site Infection (Disorders) (SNOMED)active2024-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1880.jsonTests for Enterobacter spp., E. coli, or Klebsiella spp. Nucleic Acidactive2025-02hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1881.jsonNU_Tests for Enterobacteriaceae species Nucleic Acidactive2024-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1882.jsonCarbapenemase production (Organism or Substance in Lab Results)active2025-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1892.jsonToxoplasmosis (Disorders) (SNOMED)active2023-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1893.jsonToxoplasmosis (Disorders) (ICD10CM)active2023-06hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1895.jsonToxoplasmosis (Organism or Substance in Lab Results)active2023-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1897.jsonToxoplasmosis (Tests by Microscopic Observation)active2023-06hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1898.jsonToxoplasmosis (Tests for Toxoplasma gondii Nucleic Acid)active2024-06hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1901.jsonToxoplasmosis (Tests for Toxoplasma gondii Antibody)active2024-06hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1902.jsonOrthopox (Disorders) (SNOMED)active2025-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1908.jsonOrganisms (Tests by Electron Microscopic Observation)active2023-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1919.jsonFungi [Causing Meningitis] (Tests by Culture and Identification Method)active2024-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1923.jsonCoronary artery aneurysm (SNOMED)active2025-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1924.jsonCoronary artery dilatation (SNOMED)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1925.jsonEctatic coronary artery (SNOMED)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1926.jsonLeft ventricular ejection fraction [Decreased Level] (SNOMED)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1927.jsonCoronary artery aneurysm (ICD10CM)active2023-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1928.jsonShock (SNOMED)active2024-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1929.jsonShock (ICD10CM)active2023-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1930.jsonTroponin [Elevated Level] (SNOMED)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1931.jsonOral mucosa Inflammation (SNOMED)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1932.jsonOral mucosa Inflammation (ICD10CM)active2023-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1933.jsonC reactive protein (Tests by Any Method)active2025-02hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1934.jsonLymphocytes [Concentration] (Tests by Any Method)active2024-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1935.jsonStrongyloidiasis (Disorders) (SNOMED)active2025-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1936.jsonStrongyloidiasis (Disorders) (ICD10CM)active2023-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1937.jsonStrongyloidiasis (Tests for Strongyloides Nucleic Acid)active2023-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1938.jsonStrongyloidiasis (Tests for Strongyloides stercoralis IgG Antibody)active2023-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1939.jsonStrongyloidiasis (Tests for Strongyloides stercoralis IgG Antibody in Blood)active2023-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1940.jsonOrganisms (Tests by Microscopic Observation in Stool)active2023-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1941.jsonStrongyloidiasis (Organism or Substance in Lab Results)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1942.jsonStrongyloidiasis [Strongyloides stercoralis] (Organism or Substance in Lab Results)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1943.jsonJamestown Canyon Virus Diseases (Disorders) (SNOMED)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1944.jsonJamestown Canyon Virus Diseases (Tests for Jamestown Canyon Virus Nucleic Acid)active2023-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1945.jsonJamestown Canyon Virus Diseases (Tests for Jamestown Canyon Virus IgM Antibody)active2023-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1946.jsonJamestown Canyon Virus Diseases (Tests for Jamestown Canyon Virus Antibody)active2023-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1947.jsonJamestown Canyon Virus Diseases (Organism or Substance in Lab Results)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1948.jsonKeystone Virus Diseases (Disorders) (SNOMED)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1949.jsonLa Crosse Virus Diseases (Disorders) (SNOMED)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1950.jsonSnowshoe hare Virus Diseases (Disorders) (SNOMED)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1951.jsonTrivittatus Virus Diseases (Disorders) (SNOMED)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1952.jsonLa Crosse Virus Diseases (Tests for La Crosse Virus Nucleic Acid)active2023-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1953.jsonSnowshoe hare Virus Diseases (Tests for Snowshoe hare Virus Nucleic Acid)active2023-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1954.jsonLa Crosse Virus Diseases (Tests for La Crosse Virus IgM Antibody)active2023-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1955.jsonSnowshoe hare Virus Diseases (Tests for Snowshoe hare Virus IgM Antibody)active2023-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1956.jsonLa Crosse Virus Diseases (Tests for La Crosse Virus Antibody)active2023-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1957.jsonSnowshoe hare Virus Diseases (Tests for Snowshoe hare Virus Antibody)active2023-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1958.jsonTrivittatus Virus Diseases (Tests for Trivittatus Virus Antibody)active2023-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1959.jsonKeystone Virus Diseases (Organism or Substance in Lab Results)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1960.jsonLa Crosse Virus Diseases (Organism or Substance in Lab Results)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1961.jsonSnowshoe hare Virus Diseases (Organism or Substance in Lab Results)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1962.jsonTrivittatus Virus Diseases (Organism or Substance in Lab Results)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1963.jsonHepatitis C Virus Infection, Perinatal (Disorders) (SNOMED)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1964.jsonEncephalomyelitis (SNOMED)active2024-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1965.jsonEncephalomyelitis (ICD10CM)active2023-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1966.jsonDrug Overdose and Poisoning [Non opioid] [Muscle Relaxant] (SNOMED)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1967.jsonDrug Overdose and Poisoning [Non opioid] [Muscle Relaxant] (ICD10CM)active2023-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1968.jsonHepatitis D Virus Infection (Disorders) (SNOMED)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1969.jsonHepatitis D Virus Infection (Disorders) (ICD10CM)active2023-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1970.jsonNU_Hepatitis D Virus Infection (Tests for hepatitis D virus total or IgG Antibody)active2024-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1971.jsonHepatitis D Virus Infection (Tests for hepatitis D virus IgM Antibody)active2023-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1972.jsonHepatitis D Virus Infection (Tests for hepatitis D virus Nucleic Acid)active2023-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1973.jsonHepatitis D Virus Infection (Organism or Substance in Lab Results)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1974.jsonBaylisascariasis (Disorders) (SNOMED)active2025-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1975.jsonBaylisascariasis (Organism or Substance in Lab Results)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1976.jsonBaylisascariasis (Tests for Baylisascaris species Antibody)active2023-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1978.jsonLarva Migrans (Neural, Ocular, or Visceral) (SNOMED)active2024-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1979.jsonLarva Migrans (Neural, Ocular, or Visceral) (ICD10CM)active2023-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1980.jsonCalifornia Serogroup Virus Disease [Unspecified] (Disorders) (SNOMED)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1981.jsonCalifornia Serogroup Virus Disease [Unspecified] (Disorders) (ICD10CM)active2023-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1982.jsonCalifornia Serogroup Virus Disease [Unspecified] (Organism or Substance in Lab Results)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1983.jsonCalifornia Serogroup Virus Disease [Unspecified] (Tests for California Serogroup Virus Nucleic Acid)active2023-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1984.jsonCalifornia Serogroup Virus Disease [Unspecified] (Tests for California Serogroup Virus IgM Antibody)active2023-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1985.jsonCalifornia Serogroup Virus Disease [Unspecified] (Tests for California Serogroup Virus Antibody)active2023-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1986.jsonPregnant (ICD10CM)active2023-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1987.jsonFlank Pain (SNOMED)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1988.jsonBone Pain (SNOMED)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1989.jsonAbscess (SNOMED)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1990.jsonAbscess (ICD10CM)active2023-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1991.jsonFocal Brain Lesions (SNOMED)active2025-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1992.jsonPathologic Fractures [Unspecified Cause] (SNOMED)active2025-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1993.jsonPathologic Fractures [Unspecified Cause] (ICD10CM)active2023-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1994.jsonGranulomas (SNOMED)active2025-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1995.jsonGranulomas (ICD10CM)active2024-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1996.jsonSkin Lesions (SNOMED)active2025-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1997.jsonSkin Lesions (ICD10CM)active2024-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1998.jsonAngiostrongyliasis (Disorders) (SNOMED)active2025-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1999.jsonLymphocytic Choriomeningitis (Disorders) (SNOMED)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2000.jsonLymphocytic Choriomeningitis (Disorders) (ICD10CM)active2023-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2001.jsonLymphocytic Choriomeningitis (Organism or Substance in Lab Results)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2002.jsonLymphocytic Choriomeningitis (Tests for LCMV Nucleic Acid)active2023-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2003.jsonLymphocytic Choriomeningitis (Tests for LCMV Nucleic Acid in CSF or Blood)active2023-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2004.jsonLymphocytic Choriomeningitis (Tests for LCMV Antibody)active2023-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2005.jsonLymphocytic Choriomeningitis (Tests for LCMV Antibody in CSF or Serum)active2023-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2006.jsonAngiostrongyliasis (Disorders) (ICD10CM)active2023-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2007.jsonEosinophilic meningitis (SNOMED)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2009.jsonAngiostrongyliasis (Tests for Angiostrongylus Nucleic Acid)active2023-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2010.jsonEosinophils [Concentration] (Tests in CSF by Any Method)active2023-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2011.jsonEosinophils [Percentage] (Tests in CSF by Any Method)active2023-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2012.jsonMpox (Tests for mpox virus by Genomic Sequencing)active2023-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2013.jsonMpox (Test Panels for mpox virus by Genomic Sequencing)active2023-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2017.jsonRash [Macular, Papular, Vesicular, Pustular, or Centrifugal] (SNOMED)active2024-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2018.jsonInterpretation of an Observation (High)active2023-01hl7tho
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2019.jsonInterpretation of an Observation (Low)active2024-06hl7tho
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.202.jsonTrichinellosis (Disorders) (SNOMED)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2020.jsonLymphadenopathy [Acute] (SNOMED)active2025-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2023.jsonTick Paralysis (Disorders) (SNOMED)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2024.jsonBacillary angiomatosis (Disorders) (SNOMED)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2025.jsonAnimal Bite or Scratch [Cat] (Disorders) (SNOMED)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2026.jsonAnimal Bite or Scratch [Cat] (Disorders) (ICD10CM)active2024-06hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2027.jsonBartonellosis (Disorders) (SNOMED)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2028.jsonBartonellosis (Disorders) (ICD10CM)active2023-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2029.jsonBartonellosis (Organism or Substance in Lab Results)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2030.jsonBartonella henselae infection (Disorders) (SNOMED)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2031.jsonBartonella quintana infection (Disorders) (SNOMED)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2032.jsonBartonella bacilliformis infection (Disorders) (SNOMED)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2033.jsonBartonella henselae infection (Disorders) (ICD10CM)active2023-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2034.jsonBartonella quintana infection (Disorders) (ICD10CM)active2023-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2036.jsonBartonella henselae (Organism or Substance in Lab Results)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2037.jsonBartonella quintana (Organism or Substance in Lab Results)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2038.jsonBartonella bacilliformis (Organism or Substance in Lab Results)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2039.jsonBartonella quintana infection (Tests for Bartonella quintana Nucleic Acid)active2023-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.204.jsonGiardiasis (Disorders) (SNOMED)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2040.jsonBartonella quintana infection (Tests for Bartonella quintana IgM Antibody in a clinical specimen by any method)active2023-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2041.jsonBartonella quintana infection (Tests for Bartonella quintana IgG or Total Antibody in a clinical specimen by any method)active2023-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2042.jsonBartonella henselae infection (Tests for Bartonella henselae Nucleic Acid)active2023-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2043.jsonBartonella henselae infection (Tests for Bartonella henselae IgM Antibody in a clinical specimen by any method)active2023-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2044.jsonBartonella henselae infection (Tests for Bartonella henselae IgG or Total Antibody in a clinical specimen by any method)active2023-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2045.jsonBartonella bacilliformis infection (Tests for Bartonella bacilliformis IgM Antibody in a clinical specimen by any method)active2023-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2046.jsonBartonella bacilliformis infection (Tests for Bartonella bacilliformis IgG or Total Antibody in a clinical specimen by any method)active2023-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2047.jsonBartonellosis (Tests for Bartonella spp. Nucleic Acid)active2025-02hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2048.jsonBartonellosis (Tests for Bartonella spp. IgM Antibody in a clinical specimen by any method)active2023-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2049.jsonBartonella spp. (Tests by Microscopic Observation)active2023-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2050.jsonBartonellosis (Tests for Bartonella spp. by Culture and Identification Method)active2023-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2051.jsonBartonellosis (Tests for Bartonella spp. IgG or Total Antibody in a clinical specimen by any method)active2023-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2052.jsonEchinococcosis (Disorders) (SNOMED)active2024-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2053.jsonEchinococcosis (Disorders) (ICD10CM)active2023-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2054.jsonCystic Echinococcosis (Disorders) (SNOMED)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2055.jsonCystic Echinococcosis (Disorders) (ICD10CM)active2023-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2056.jsonAlveolar Echinococcosis (Disorders) (SNOMED)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2057.jsonAlveolar Echinococcosis (Disorders) (ICD10CM)active2023-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2058.jsonEchinococcosis (Tests for Echinococcus species Antibody)active2024-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2059.jsonEchinococcus species (Tests by Microscopic Observation)active2023-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2060.jsonEchinococcosis (Organism or Substance in Lab Results)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2061.jsonGenital Warts (Disorders) (SNOMED)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2062.jsonPseudomembrane [Nose, pharynx, tonsils, or larynx] (SNOMED)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2063.jsonGenital Warts (Disorders) (ICD10CM)active2023-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2064.jsonDiphyllobothriasis (Disorders) (SNOMED)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2065.jsonDiphyllobothriasis (Disorders) (ICD10CM)active2023-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2066.jsonDiphyllobothriasis (Organism or Substance in Lab Results)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2067.jsonNontuberculous Mycobacteria Infection, Pulmonary (Tests for Mycobacterium species Nucleic Acid in a Pulmonary Specimen)active2023-06hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2068.jsonAngiostrongyliasis (Organism or Substance in Lab Results)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2069.jsonPelvic Inflammatory Disease (Disorders) (SNOMED)active2025-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2070.jsonPelvic Inflammatory Disease [nonGC and nonCT] (Disorders) (SNOMED)active2025-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2071.jsonPelvic Inflammatory Disease [Unspecified] (Disorders) (SNOMED)active2025-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2072.jsonPelvic Inflammatory Disease (Disorders) (ICD10CM)active2024-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2073.jsonPelvic Inflammatory Disease [nonGC and nonCT] (Disorders) (ICD10CM)active2024-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2074.jsonPelvic Inflammatory Disease [Unspecified] (Disorders) (ICD10CM)active2024-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2075.jsonLower Abdominal Tenderness (SNOMED)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2076.jsonLower Abdominal Tenderness (ICD10CM)active2023-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2077.jsonTenderness with motion of the cervix (SNOMED)active2025-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2078.jsonAdnexal Tenderness (SNOMED)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2079.jsonUterine Tenderness (SNOMED)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2080.jsonLeukocytosis (SNOMED)active2024-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2081.jsonLeukocytosis (ICD10CM)active2023-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2082.jsonPurulent material in the peritoneal cavity (SNOMED)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2083.jsonPelvic Abscess (SNOMED)active2025-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2084.jsonPelvic Abscess (ICD10CM)active2023-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2085.jsonLeukocytes [Concentration] (Tests in Blood by Any Method)active2023-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2087.jsonNongonococcal Urethritis (Disorders) (SNOMED)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2088.jsonNongonococcal Urethritis (Disorders) (ICD10CM)active2023-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2089.jsonUrethritis (SNOMED)active2024-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2090.jsonUrethritis (ICD10CM)active2023-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2091.jsonUrethral discharge (SNOMED)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2092.jsonUrethral discharge (ICD10CM)active2023-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2093.jsonDysuria (SNOMED)active2023-01hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2094.jsonDysuria (ICD10CM)active2023-01hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2095.jsonGonorrhea (Tests for Neisseria gonorrhoeae Antigen)active2023-01hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.2096.jsonCyanobacteria and Cyanotoxin Poisoning (Disorders) (SNOMED)active2024-01hl7sct